This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Sanders, D B. Articles by Larson, D. Search for Related Content PubMed PubMed Citation Articles by Sanders, D B. Articles by Larson, D. Social Bookmarking                   What's this?

The role of nitric oxide synthase/nitric oxide in vascular smooth muscle control

Circulatory Sciences Graduate Perfusion Program, Sarver Heart Center, University of Arizona, Tucson, Arizona

Tara Kelley

Circulatory Sciences Graduate Perfusion Program, Sarver Heart Center, University of Arizona, Tucson, Arizona

Douglas Larson

Circulatory Sciences Graduate Perfusion Program, Sarver Heart Center, University of Arizona, Tucson, Arizona

Vascular compliance is dependent on endogenous and exogenous sources of nitric oxide (NO). In a discussion of therapeutics and NO derived via nitric oxide synthase (NOS) enzymes, it is necessary to examine the pathways of each drug to provide the clinical perfusionist with a greater understanding of the role of NOS/NO in vascular function. Endothelial-derived NO is a contributor in the vasoregulation of vascular smooth muscle. Therapeutics seek to mimic the vasodilatory effects of the endogenous NO. The therapeutics included in this review are nitroglycerin, nitroprusside, amyl nitrite, and inhalation of NO. L-Arginine supplementation provides additional substrate for the endogenous pathway that can augment NO production. NO is a small bioactive molecule involved in various biochemical pathways. Dysregulation of NO production can impair normal physiologic control of vascular compliance. Therefore, the purpose of this review is to provide the perfusionist with an understanding of the biochemical and pharmacological aspects of NOS/NO associated with vascular function.

Perfusion, Vol. 15, No. 2, 97-104 (2000)
DOI: 10.1177/026765910001500203


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. W.L. Hartog, A. A. Voors, S. J.L. Bakker, A. J. Smit, and D. J. van Veldhuisen Advanced glycation end-products (AGEs) and heart failure: Pathophysiology and clinical implications Eur J Heart Fail, December 1, 2007; 9(12): 1146 - 1155. [Abstract] [Full Text] [PDF]

				R. M. Fryer, J. A. Segreti, D. L. Widomski, P. H. Franklin, P. N. Banfor, K. A. Koch, M. Nakane, J. R. Wu-Wong, B. F. Cox, and G. A. Reinhart Systemic Activation of the Calcium Sensing Receptor Produces Acute Effects on Vascular Tone and Circulatory Function in Uremic and Normal Rats: Focus on Central versus Peripheral Control of Vascular Tone and Blood Pressure by Cinacalcet J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 217 - 226. [Abstract] [Full Text] [PDF]

				A. Mollerlokken, V. J. Berge, A. Jorgensen, U. Wisloff, and A. O. Brubakk Effect of a short-acting NO donor on bubble formation from a saturation dive in pigs J Appl Physiol, December 1, 2006; 101(6): 1541 - 1545. [Abstract] [Full Text] [PDF]

				P. McDonough, A. M. Jones, and D. C. Poole Nitric oxide and muscle VO2 kinetics J. Physiol., June 1, 2006; 573(2): 565 - 566. [Full Text] [PDF]

				A. E. Linder, L. P. McCluskey, K. R. Cole III, K. M. Lanning, and R. C. Webb Dynamic Association of Nitric Oxide Downstream Signaling Molecules with Endothelial Caveolin-1 in Rat Aorta J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 9 - 15. [Abstract] [Full Text] [PDF]

				R. Budhiraja and P. M. Hassoun Portopulmonary Hypertension: A Tale of Two Circulations Chest, February 1, 2003; 123(2): 562 - 576. [Abstract] [Full Text] [PDF]

				R. H. CROSBIE, R. BARRESI, and K. P. CAMPBELL Loss of sarcolemma nNOS in sarcoglycan-deficient muscle FASEB J, November 1, 2002; 16(13): 1786 - 1791. [Abstract] [Full Text] [PDF]

				K. Chitaley and R. C. Webb Nitric Oxide Induces Dilation of Rat Aorta via Inhibition of Rho-Kinase Signaling Hypertension, February 1, 2002; 39(2): 438 - 442. [Abstract] [Full Text] [PDF]